General Statement of Disclosure:
CONSULTING FEES/HONORARIA: Cordis(MODEST) SPEAKER'S BUREAU: Jannsen Pharmaceuticals(SIGNIFICANT), Terumo(MODEST) EQUITY INTERESTS/STOCK OPTIONS: Frond Medical(SIGNIFICANT)
CONSULTING FEES/HONORARIA: Cordis(MODEST) SPEAKER'S BUREAU: Jannsen Pharmaceuticals(SIGNIFICANT), Terumo(MODEST) EQUITY INTERESTS/STOCK OPTIONS: Frond Medical(SIGNIFICANT)
© 2024 American College of Cardiology Foundation. All rights reserved.